These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2774618)

  • 21. Progression of orthostatic proteinuria to focal and segmental glomerulosclerosis.
    Berns JS; McDonald B; Gaudio KM; Siegel NJ
    Clin Pediatr (Phila); 1986 Mar; 25(3):165-6. PubMed ID: 3948459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgM-associated mesangial proliferative glomerulonephritis and focal and segmental hyalinosis with nephrotic syndrome.
    Aubert J; Humair L; Chatelanat F; de Torrenté A
    Am J Nephrol; 1985; 5(6):445-9. PubMed ID: 4083317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study.
    Futrakul P; Poshyachinda M; Mitrakul C
    Clin Nephrol; 1978 Nov; 10(5):180-6. PubMed ID: 729213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis.
    Wee Leng G; Mustafar R; Kamaruzaman L; Mohd R; Cader RA; Wei Yen K; Kiew Bing P
    Acta Med Indones; 2018 Jul; 50(3):237-243. PubMed ID: 30333274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin.
    Walker RG; Kincaid-Smith P
    Nephron; 1990; 54(2):117-21. PubMed ID: 2179754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical studies with the new saluretic azosemide].
    Kokot F; Liebera T; Wnuk R
    Z Gesamte Inn Med; 1982 Mar; 37(6):180-3. PubMed ID: 7090459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal segmental glomerulosclerosis and nephrotic syndrome in a child with embryonal rhabdomyosarcoma.
    Olowu WA; Salako AA; Adelusola KA; Sowande OA; Adetiloye VA; Adefehinti O; Osasan SA
    Clin Exp Nephrol; 2008 Apr; 12(2):144-148. PubMed ID: 18175060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of focal segmental glomerulosclerosis syndrome secondary to high-altitude polycythemia.
    Yin Q; Yang Y; He T; Lai C; Liang Y; Jiang W; Wang H; Tang X; Diao Y; Huang S; Fu P; Liu F
    Ren Fail; 2014 Feb; 36(1):108-10. PubMed ID: 24059478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current trends in the treatment of primary glomerulonephritis].
    Ponticelli C; Passerini P
    Minerva Urol Nefrol; 1984; 36(4 Suppl):7-13. PubMed ID: 6398922
    [No Abstract]   [Full Text] [Related]  

  • 30. Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome.
    Salcedo JR; Ruley EJ; Bock GH
    J Pediatr; 1983 Feb; 102(2):325-6. PubMed ID: 6822951
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal tubular defect in nephrotic syndrome associated with focal segmental glomerulosclerosis.
    Futrakul P; Poshyachinda M; Preeyasombati C; Sensirivatana R; Watana D
    Nephron; 1991; 59(4):660-1. PubMed ID: 1766509
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of primary chronic glomerulonephritis].
    Risler T; Braun N; Erley CM
    Ther Umsch; 1994 Dec; 51(12):807-12. PubMed ID: 7784993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
    Hogan J; Radhakrishnan J
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal and segmental glomerulosclerosis in preeclamptic patients with nephrotic syndrome.
    Shiiki H; Dohi K; Hanatani M; Fujii Y; Sanai H; Ichijo M; Shimamoto I; Ishikawa H; Watanabe T
    Am J Nephrol; 1990; 10(3):205-12. PubMed ID: 2382682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis].
    Kacprzyk F; Chrzanowski W; Kubala L; Orłowski Z
    Pol Merkur Lekarski; 1997 Feb; 2(8):96-8. PubMed ID: 9538648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of angiotensin converting enzyme inhibitors for the treatment of focal segmental glomerulosclerosis.
    Fitzwater DS; Brouhard BH; Cunningham RJ
    Am J Dis Child; 1990 May; 144(5):522. PubMed ID: 2330915
    [No Abstract]   [Full Text] [Related]  

  • 37. [Nephrotic syndrome in childhood].
    Reusz G; Szabó A; Fekete A
    Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
    Bazzi C; Petrini C; Rizza V; Napodano P; Paparella M; Arrigo G; Pisano L; D'Amico G
    Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Focal-segmental sclerosis. Importance of early diagnosis].
    Balli F; Genova R
    Minerva Pediatr; 1977 Mar; 29(8):551-4. PubMed ID: 865436
    [No Abstract]   [Full Text] [Related]  

  • 40. [Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results].
    Imbasciati E; Cagnoli L; Case N; Pasquali S; Di Filippo G; Limido D; Cornalba L; Volpini T; Pozzi C; Zuccelli P; Ponticelli C
    Minerva Nefrol; 1980; 27(4):571-5. PubMed ID: 7019771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.